Skip to content

Wabash National WNC Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Segments

By product

See full
New trailers67.6%+10.3%
Equipment and other21.2%-29.6%
Components, parts and services10.9%+31.3%
Used trailers0.3%-25.0%

Other financials

Income statement

See full
Revenue$303.2M-20.4%
Gross profit-$10.6M-156%
Operating income-$52.4M-117%
Net income-$45.2M-120%
EPS (diluted)-$1.11-121%

Balance sheet

See full
Cash & equivalents$43.4M-46.4%
Total debt$531.0M+17.1%
Total equity$320.6M-20.6%
Total assets$1.2B-13.1%

Cash flow

See full
Operating cash flow-$33.7M-12,272%
CapEx$3.4M-60.6%
Free cash flow-$37.1M-313%

Valuation

See full
Market cap$567M+32.6%
Enterprise value$1.05B+31.8%
P/S0.4×+0.2×

Profitability

See full
Gross margin2.8%-8.7pp
Operating margin22.4%+16.2pp
Net margin-4.4%+0.6pp
FCF margin-2.8%-6.8pp

Returns & leverage

See full
Return on equity-17.9%+4.2pp
Debt / equity1.7×+0.5×
Current ratio1.3×-0.3×